Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy

Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, foll...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 359; pp. 347 - 358
Main Authors He, Yu, Chen, Qi-Wen, Yu, Jin-Xin, Qin, Si-Yong, Liu, Wen-Long, Ma, Yi-Han, Chen, Xiao-Sui, Zhang, Ai-Qing, Zhang, Xian-Zheng, Cheng, Yin-Jia
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O6-BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O6-BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies. PLGA-based bioinspired platform for tumor-specific retention and enhanced colorectal cancer therapy. [Display omitted]
AbstractList Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O6-BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O6-BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies. PLGA-based bioinspired platform for tumor-specific retention and enhanced colorectal cancer therapy. [Display omitted]
Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O -benzylguanine (O -BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O -BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O -BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies.
Author Liu, Wen-Long
Chen, Qi-Wen
Yu, Jin-Xin
Chen, Xiao-Sui
Cheng, Yin-Jia
Zhang, Ai-Qing
Qin, Si-Yong
Ma, Yi-Han
He, Yu
Zhang, Xian-Zheng
Author_xml – sequence: 1
  givenname: Yu
  surname: He
  fullname: He, Yu
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 2
  givenname: Qi-Wen
  surname: Chen
  fullname: Chen, Qi-Wen
  organization: Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry Wuhan University, Wuhan 430072, People's Republic of China
– sequence: 3
  givenname: Jin-Xin
  surname: Yu
  fullname: Yu, Jin-Xin
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 4
  givenname: Si-Yong
  surname: Qin
  fullname: Qin, Si-Yong
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 5
  givenname: Wen-Long
  surname: Liu
  fullname: Liu, Wen-Long
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 6
  givenname: Yi-Han
  surname: Ma
  fullname: Ma, Yi-Han
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 7
  givenname: Xiao-Sui
  surname: Chen
  fullname: Chen, Xiao-Sui
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 8
  givenname: Ai-Qing
  surname: Zhang
  fullname: Zhang, Ai-Qing
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
– sequence: 9
  givenname: Xian-Zheng
  surname: Zhang
  fullname: Zhang, Xian-Zheng
  organization: Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry Wuhan University, Wuhan 430072, People's Republic of China
– sequence: 10
  givenname: Yin-Jia
  surname: Cheng
  fullname: Cheng, Yin-Jia
  email: ChengYJ@mail.scuec.edu.cn
  organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37277054$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1LxDAQhoMouqv-BKVHL635bnuSZdFVWNCDCp5Cmk60S9vUpCv4703Z1aswZC7PzOR95uiwdz0gdEFwRjCR15tsY1zvoc0opizDIsOcHaAZKXKW8rIUh2gWuSJlUpQnaB7CBmMsGM-P0QnLaZ5jwWfo9Q10GBMDbZt00FVe95Aa3bmtbfU71MnTerVIet27QfuxMS0kQ6tH63yXxCeB_kP3JnJmaj4ZP8Dr4fsMHVndBjjf91P0cnf7vLxP14-rh-VinZr4rTEVOZOFtYZKUxtdVsSWXJYVFTWLJaUtpK2sIKXhnOgaWFlQgo2sWW254Iadoqvd3sG7zy2EUXVNmMLEGG4bFC0ow5zmkkZU7FDjXQgerBp802n_rQhWk1K1UXulalKqsFBRaZy73J_YVh3Uf1O_DiNwswMgBv1qwKtgGpikNB7MqGrX_HPiB2DZjMQ
CitedBy_id crossref_primary_10_1021_accountsmr_4c00116
crossref_primary_10_1016_j_cclet_2024_109657
crossref_primary_10_1016_j_jddst_2024_105812
crossref_primary_10_4155_tde_2023_0027
Cites_doi 10.1038/sj.bjc.6604366
10.1016/j.mattod.2017.05.006
10.1016/j.foodhyd.2020.106284
10.3389/fvets.2020.00042
10.6023/cjoc201803050
10.1016/j.ijbiomac.2020.07.228
10.7150/thno.35353
10.1016/j.biomaterials.2013.07.097
10.1002/cncr.33349
10.1016/j.addr.2011.12.009
10.3390/biom13050768
10.3390/polym13203471
10.1080/1061186X.2016.1238091
10.1016/j.ijpharm.2009.07.005
10.1021/acs.molpharmaceut.8b00957
10.1126/sciadv.abf0677
10.1182/blood-2004-03-1140
10.1016/j.ejpb.2015.06.014
10.1021/acsnano.2c02540
10.1016/j.ijbiomac.2022.08.173
10.1007/s10118-022-2726-0
10.7150/thno.38081
10.1016/j.carbpol.2016.12.009
10.3748/wjg.v17.i13.1666
10.1016/j.cej.2017.02.003
10.1002/med.21809
10.1002/adma.202100701
10.1053/j.gastro.2008.02.098
10.1158/1538-7445.AM2018-CT095
10.3945/ajcn.2008.26701
10.1002/smtd.202100951
10.1093/abbs/gmq125
10.1038/nature07774
10.1002/adfm.202009733
10.1021/nn503735w
10.3109/08941939709032139
10.1016/j.reactfunctpolym.2019.104459
10.1016/j.redox.2020.101495
10.1016/j.carbpol.2020.117255
10.18632/oncotarget.7896
10.1007/s00894-016-3133-7
10.1016/j.ijbiomac.2016.08.080
ContentType Journal Article
Copyright 2023 Elsevier B.V.
Copyright © 2023 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2023 Elsevier B.V.
– notice: Copyright © 2023 Elsevier B.V. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jconrel.2023.05.043
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-4995
EndPage 358
ExternalDocumentID 10_1016_j_jconrel_2023_05_043
37277054
S0168365923003565
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AABXZ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEZYN
AFKWA
AFRZQ
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
D-I
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SPT
SSM
SSP
SSZ
T5K
TEORI
WUQ
~G-
AAHBH
AAXKI
AFJKZ
AKRWK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c365t-57368ffc26cdca9b1f9469b25d35d366f86fbf519c441ade398210c6d3df454c3
IEDL.DBID AIKHN
ISSN 0168-3659
IngestDate Fri Aug 16 10:19:42 EDT 2024
Thu Sep 26 19:15:51 EDT 2024
Sat Sep 28 08:10:22 EDT 2024
Fri Feb 23 02:34:21 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Colorectal cancer therapy
Oral drug delivery system
PLGA
Temozolomide
Tumor-specific accumulation
Yeast shell wall
Language English
License Copyright © 2023 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c365t-57368ffc26cdca9b1f9469b25d35d366f86fbf519c441ade398210c6d3df454c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 37277054
PQID 2823042762
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_2823042762
crossref_primary_10_1016_j_jconrel_2023_05_043
pubmed_primary_37277054
elsevier_sciencedirect_doi_10_1016_j_jconrel_2023_05_043
PublicationCentury 2000
PublicationDate July 2023
2023-Jul
2023-07-00
20230701
PublicationDateYYYYMMDD 2023-07-01
PublicationDate_xml – month: 07
  year: 2023
  text: July 2023
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of controlled release
PublicationTitleAlternate J Control Release
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Han, Yin, Ye, Tan, Shi, He, Wang, Wu, Ye, Guo (bb0070) 2018; 38
Verma, Gokhale, Burgess (bb0105) 2009; 380
Morano, Corallo, Barault, Niger, Berenato, Moretto, Fucà, Randon, Antista, Belfiore (bb0035) 2018; 78
Lin, Mukherjee, Li, Hou, Pan, Liu (bb0185) 2021; 7
Larrea, Clemente, Luque-Michel, Sebastian (bb0110) 2017; 316
Pei, Jia, Li, Liu (bb0140) 2018; 16
Wang, Sun, Fan, Du (bb0020) 2022; 40
Herre, Marshall, Caron, Edwards, Williams, Schweighoffer, Tybulewicz, Sousa, Gordon, Brown (bb0165) 2004; 104
Miao, Chen, Chen, Mi, Lin, Chang, Chiang, Wang, Lin, Sung (bb0100) 2021; 33
Kang, Choi, Lee, Lee, Kim, Jang, Tunsirikongkon, Kim, Park (bb0075) 2017; 159
Stephen, Kievit, Veiseh, Chiarelli, Fang, Wang, Hatzinger, Ellenbogen, Silber, Zhang (bb0045) 2014; 8
Qian, Zheng, Wang, Tang, Zhang, Zhang, Huang, Pei, Jiang (bb0055) 2013; 34
Frank, Onzi, Morawski, Pohlmann, Guterres, Contri (bb0080) 2020; 147
Sipos, Műzes (bb0090) 2011; 17
Zhou, Ling, Liu, Zhang, Ding, Dong, Liang, Li, Zhang (bb0215) 2019; 9
Zhang, Xu, Chen, Dou, Zhou, Li, Li, An, Tao, Hu (bb0220) 2017; 20
Chai, Liu, Tian, Li, Tang (bb0015) 2011; 43
Kim, Patel, Patel (bb0060) 2021; 13
Esquivel, Bhatt, Diwan, Habib, Lee, Khatun, Nurunnabi (bb0195) 2023; 13
Qin, Xie, Xue, Li, Gan, Zhu, Sun (bb0155) 2021; 112
Thakur, Thotakura, Kumar, Kumar, Singh, Chitkara, Raza (bb0120) 2016; 93
Saxena, Thompson, Sharp (bb0095) 1997; 10
Yu, Chen, Guo, Wang, Feng, Kong, Hong (bb0130) 2015; 10
Liu, Yao, Li, Wang, Jiang (bb0050) 2017; 25
Aouadi, Tesz, Nicoloro, Wang, Chouinard, Soto, Ostroff, Czech (bb0125) 2009; 458
Chugh, Ballman, Helman, Patel, Whelan, Widemann, Lu, Hawkins, Mascarenhas, Glod (bb0160) 2021; 127
Khalilian, Mirzaei, Taherpour (bb0145) 2016; 22
Zheng, Zhang, Liu, Wang, Cui, Pan, Liu, Tang, Wang (bb0200) 2021; 253
Peters, Boers, Haddeman, Melnikov, Qvyjt (bb0210) 2009; 89
Wolpin, Mayer (bb0010) 2008; 134
Khan, Ranson, Michael, Olver, Levitt, Mortimer, Watson, Margison, Midgley, Middleton (bb0040) 2008; 98
Faraji Dizaji, Hasani Azerbaijan, Sheisi, Goleij, Mirmajidi, Chogan, Irani, Sharafian (bb0065) 2020; 164
Ensign, Cone, Hanes (bb0180) 2012; 64
Zhang, Zheng, Li, Pan, Zeng, Pan, Zhang (bb0025) 2022; 6
Wang, Wu, Lu, Jiang, Yu (bb0085) 2020; 7
Han, Luo, Ye, Hu, Fu, Gao, Fu, Gao (bb0190) 2022; 219
Chen, Han, Zhao, Tang, Wang (bb0135) 2019; 9
Fan, Chen, Hou, Chuan, Mu, Liu, Liang, Guo, Xu (bb0170) 2021; 31
Xu, Shen, Li, Sun, Teng, Wang, Duan (bb0115) 2016; 7
Wang, Liu, Liu, Li, He, Yin, Tu, Shen, Bai, Wang (bb0205) 2020; 32
Khan, Albalawi, Pottoo (bb0005) 2022; 42
Han, Xie, Li, Shi, Wan, Chen, Wang (bb0030) 2019; 9
Zhao, Liu, He, Dong, Zhang, Xu, Kang, Xue (bb0150) 2022; 16
Ma, Fuchs, Boase, Rolfe, Coombes, Thurecht (bb0175) 2015; 94
Liu (10.1016/j.jconrel.2023.05.043_bb0050) 2017; 25
Miao (10.1016/j.jconrel.2023.05.043_bb0100) 2021; 33
Aouadi (10.1016/j.jconrel.2023.05.043_bb0125) 2009; 458
Stephen (10.1016/j.jconrel.2023.05.043_bb0045) 2014; 8
Yu (10.1016/j.jconrel.2023.05.043_bb0130) 2015; 10
Wang (10.1016/j.jconrel.2023.05.043_bb0020) 2022; 40
Larrea (10.1016/j.jconrel.2023.05.043_bb0110) 2017; 316
Han (10.1016/j.jconrel.2023.05.043_bb0030) 2019; 9
Sipos (10.1016/j.jconrel.2023.05.043_bb0090) 2011; 17
Kang (10.1016/j.jconrel.2023.05.043_bb0075) 2017; 159
Fan (10.1016/j.jconrel.2023.05.043_bb0170) 2021; 31
Zhao (10.1016/j.jconrel.2023.05.043_bb0150) 2022; 16
Frank (10.1016/j.jconrel.2023.05.043_bb0080) 2020; 147
Chai (10.1016/j.jconrel.2023.05.043_bb0015) 2011; 43
Peters (10.1016/j.jconrel.2023.05.043_bb0210) 2009; 89
Morano (10.1016/j.jconrel.2023.05.043_bb0035) 2018; 78
Pei (10.1016/j.jconrel.2023.05.043_bb0140) 2018; 16
Zhang (10.1016/j.jconrel.2023.05.043_bb0220) 2017; 20
Verma (10.1016/j.jconrel.2023.05.043_bb0105) 2009; 380
Chen (10.1016/j.jconrel.2023.05.043_bb0135) 2019; 9
Xu (10.1016/j.jconrel.2023.05.043_bb0115) 2016; 7
Herre (10.1016/j.jconrel.2023.05.043_bb0165) 2004; 104
Ma (10.1016/j.jconrel.2023.05.043_bb0175) 2015; 94
Khan (10.1016/j.jconrel.2023.05.043_bb0005) 2022; 42
Wolpin (10.1016/j.jconrel.2023.05.043_bb0010) 2008; 134
Zhang (10.1016/j.jconrel.2023.05.043_bb0025) 2022; 6
Wang (10.1016/j.jconrel.2023.05.043_bb0205) 2020; 32
Chugh (10.1016/j.jconrel.2023.05.043_bb0160) 2021; 127
Khalilian (10.1016/j.jconrel.2023.05.043_bb0145) 2016; 22
Faraji Dizaji (10.1016/j.jconrel.2023.05.043_bb0065) 2020; 164
Esquivel (10.1016/j.jconrel.2023.05.043_bb0195) 2023; 13
Thakur (10.1016/j.jconrel.2023.05.043_bb0120) 2016; 93
Zheng (10.1016/j.jconrel.2023.05.043_bb0200) 2021; 253
Wang (10.1016/j.jconrel.2023.05.043_bb0085) 2020; 7
Kim (10.1016/j.jconrel.2023.05.043_bb0060) 2021; 13
Saxena (10.1016/j.jconrel.2023.05.043_bb0095) 1997; 10
Qian (10.1016/j.jconrel.2023.05.043_bb0055) 2013; 34
Han (10.1016/j.jconrel.2023.05.043_bb0190) 2022; 219
Lin (10.1016/j.jconrel.2023.05.043_bb0185) 2021; 7
Qin (10.1016/j.jconrel.2023.05.043_bb0155) 2021; 112
Ensign (10.1016/j.jconrel.2023.05.043_bb0180) 2012; 64
Zhou (10.1016/j.jconrel.2023.05.043_bb0215) 2019; 9
Han (10.1016/j.jconrel.2023.05.043_bb0070) 2018; 38
Khan (10.1016/j.jconrel.2023.05.043_bb0040) 2008; 98
References_xml – volume: 34
  start-page: 8968
  year: 2013
  ident: bb0055
  article-title: Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy
  publication-title: Biomaterials
  contributor:
    fullname: Jiang
– volume: 13
  start-page: 768
  year: 2023
  ident: bb0195
  article-title: β-Glucan and fatty acid based mucoadhesive carrier for gastrointestinal tract specific local and sustained drug delivery
  publication-title: Biomolecules
  contributor:
    fullname: Nurunnabi
– volume: 159
  start-page: 39
  year: 2017
  ident: bb0075
  article-title: Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles
  publication-title: Carbohydr. Polym.
  contributor:
    fullname: Park
– volume: 112
  year: 2021
  ident: bb0155
  article-title: Effect of acid and oxidative degradation on the structural, rheological, and physiological properties of oat β-glucan
  publication-title: Food Hydrocoll.
  contributor:
    fullname: Sun
– volume: 42
  start-page: 227
  year: 2022
  ident: bb0005
  article-title: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment
  publication-title: Med. Res. Rev.
  contributor:
    fullname: Pottoo
– volume: 94
  start-page: 393
  year: 2015
  ident: bb0175
  article-title: The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: evaluation of their potential for colon-specific delivery
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Thurecht
– volume: 16
  start-page: 227
  year: 2018
  ident: bb0140
  article-title: Versatile polymeric microspheres with tumor microenvironment bioreducible degradation, pH-activated surface charge reversal, pH-triggered “off-on” fluorescence and drug release as theranostic nanoplatforms
  publication-title: Mol. Pharm.
  contributor:
    fullname: Liu
– volume: 13
  start-page: 3471
  year: 2021
  ident: bb0060
  article-title: PLGA core-shell nano/microparticle delivery system for biomedical application
  publication-title: Polymers
  contributor:
    fullname: Patel
– volume: 127
  start-page: 1301
  year: 2021
  ident: bb0160
  article-title: SARC025 arms 1 and 2: a phase 1 study of the poly (ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma
  publication-title: Cancer
  contributor:
    fullname: Glod
– volume: 93
  start-page: 381
  year: 2016
  ident: bb0120
  article-title: Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen
  publication-title: Int. J. Biol. Macromol.
  contributor:
    fullname: Raza
– volume: 147
  year: 2020
  ident: bb0080
  article-title: Chitosan as a coating material for nanoparticles intended for biomedical applications
  publication-title: React. Funct. Polym.
  contributor:
    fullname: Contri
– volume: 7
  start-page: 42
  year: 2020
  ident: bb0085
  article-title: promotes intestinal development and regulates mucosal immune function in newborn piglets
  publication-title: Front. Vet. Sci.
  contributor:
    fullname: Yu
– volume: 9
  start-page: 1
  year: 2019
  ident: bb0135
  article-title: Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release
  publication-title: Sci. Rep.
  contributor:
    fullname: Wang
– volume: 38
  start-page: 2706
  year: 2018
  ident: bb0070
  article-title: Preparation of poly (lactic-co-glycolic acid)/polyethylene glycol nanoparticles with surface-modified aptamer S6 and its application on carrier siRNA
  publication-title: Chin. J. Org. Chem.
  contributor:
    fullname: Guo
– volume: 380
  start-page: 216
  year: 2009
  ident: bb0105
  article-title: A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Burgess
– volume: 16
  start-page: 12118
  year: 2022
  ident: bb0150
  article-title: Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment
  publication-title: ACS Nano
  contributor:
    fullname: Xue
– volume: 33
  year: 2021
  ident: bb0100
  article-title: A noninvasive gut-to-brain oral drug delivery system for treating brain tumors
  publication-title: Adv. Mater.
  contributor:
    fullname: Sung
– volume: 134
  start-page: 1296
  year: 2008
  ident: bb0010
  article-title: Systemic treatment of colorectal cancer
  publication-title: Gastroenterology
  contributor:
    fullname: Mayer
– volume: 17
  start-page: 1666
  year: 2011
  ident: bb0090
  article-title: Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?
  publication-title: World J. Gastroenterol.
  contributor:
    fullname: Műzes
– volume: 64
  start-page: 557
  year: 2012
  ident: bb0180
  article-title: Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Hanes
– volume: 32
  year: 2020
  ident: bb0205
  article-title: Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis
  publication-title: Redox Biol.
  contributor:
    fullname: Wang
– volume: 9
  start-page: 7458
  year: 2019
  ident: bb0030
  article-title: Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer
  publication-title: Theranostics
  contributor:
    fullname: Wang
– volume: 7
  start-page: eabf0677
  year: 2021
  ident: bb0185
  article-title: Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches
  publication-title: Sci. Adv.
  contributor:
    fullname: Liu
– volume: 10
  start-page: 97
  year: 1997
  ident: bb0095
  article-title: Role of organized intestinal lymphoid aggregates in intestinal regeneration
  publication-title: J. Investig. Surg.
  contributor:
    fullname: Sharp
– volume: 20
  start-page: 301
  year: 2017
  ident: bb0220
  article-title: Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease
  publication-title: Mater. Today
  contributor:
    fullname: Hu
– volume: 7
  start-page: 20890
  year: 2016
  ident: bb0115
  article-title: The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
  publication-title: Oncotarget
  contributor:
    fullname: Duan
– volume: 89
  start-page: 58
  year: 2009
  ident: bb0210
  article-title: No effect of added β-glucan or of fructooligosaccharide on appetite or energy intake
  publication-title: Am. J. Clin. Nutr.
  contributor:
    fullname: Qvyjt
– volume: 458
  start-page: 1180
  year: 2009
  ident: bb0125
  article-title: Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
  publication-title: Nature
  contributor:
    fullname: Czech
– volume: 104
  start-page: 4038
  year: 2004
  ident: bb0165
  article-title: Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages
  publication-title: Blood
  contributor:
    fullname: Brown
– volume: 25
  start-page: 235
  year: 2017
  ident: bb0050
  article-title: iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy
  publication-title: J. Drug Target.
  contributor:
    fullname: Jiang
– volume: 219
  start-page: 1244
  year: 2022
  ident: bb0190
  article-title: Research progress on natural β-glucan in intestinal diseases
  publication-title: Int. J. Biol. Macromol.
  contributor:
    fullname: Gao
– volume: 78
  start-page: CT095
  year: 2018
  ident: bb0035
  article-title: Abstract CT095: Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients (pts) bearing MGMT methylation
  publication-title: Cancer Res.
  contributor:
    fullname: Belfiore
– volume: 9
  start-page: 6568
  year: 2019
  ident: bb0215
  article-title: Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route
  publication-title: Theranostics
  contributor:
    fullname: Zhang
– volume: 164
  start-page: 1461
  year: 2020
  ident: bb0065
  article-title: Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of paclitaxel toward prostate cancer cells death
  publication-title: Int. J. Biol. Macromol.
  contributor:
    fullname: Sharafian
– volume: 98
  start-page: 1614
  year: 2008
  ident: bb0040
  article-title: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
  publication-title: Br. J. Cancer
  contributor:
    fullname: Middleton
– volume: 22
  start-page: 1
  year: 2016
  ident: bb0145
  article-title: The simulation of UV spectroscopy and electronic analysis of temozolomide and dacarbazine chemical decomposition to their metabolites
  publication-title: J. Mol. Model.
  contributor:
    fullname: Taherpour
– volume: 8
  start-page: 10383
  year: 2014
  ident: bb0045
  article-title: Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors
  publication-title: ACS Nano
  contributor:
    fullname: Zhang
– volume: 316
  start-page: 663
  year: 2017
  ident: bb0110
  article-title: Efficient production of hybrid bio-nanomaterials by continuous microchannel emulsification: dye-doped SiO2 and Au-PLGA nanoparticles
  publication-title: Chem. Eng. J.
  contributor:
    fullname: Sebastian
– volume: 43
  start-page: 217
  year: 2011
  ident: bb0015
  article-title: MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines
  publication-title: Acta Biochim. Biophys. Sin.
  contributor:
    fullname: Tang
– volume: 10
  start-page: 1743
  year: 2015
  ident: bb0130
  article-title: Specifically targeted delivery of protein to phagocytic macrophages
  publication-title: Int. J. Nanomedicine
  contributor:
    fullname: Hong
– volume: 253
  year: 2021
  ident: bb0200
  article-title: Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase
  publication-title: Carbohydr. Polym.
  contributor:
    fullname: Wang
– volume: 31
  start-page: 2009733
  year: 2021
  ident: bb0170
  article-title: Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy
  publication-title: Adv. Funct. Mater.
  contributor:
    fullname: Xu
– volume: 40
  start-page: 1154
  year: 2022
  ident: bb0020
  article-title: Intestine enzyme-responsive polysaccharide-based hydrogel to open epithelial tight junctions for oral delivery of Imatinib against colon cancer
  publication-title: Chin. J. Polym. Sci.
  contributor:
    fullname: Du
– volume: 6
  start-page: 2100951
  year: 2022
  ident: bb0025
  article-title: Temulence therapy to orthotopic colorectal tumor via oral administration of fungi-based acetaldehyde generator
  publication-title: Small Methods
  contributor:
    fullname: Zhang
– volume: 98
  start-page: 1614
  year: 2008
  ident: 10.1016/j.jconrel.2023.05.043_bb0040
  article-title: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6604366
  contributor:
    fullname: Khan
– volume: 20
  start-page: 301
  year: 2017
  ident: 10.1016/j.jconrel.2023.05.043_bb0220
  article-title: Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease
  publication-title: Mater. Today
  doi: 10.1016/j.mattod.2017.05.006
  contributor:
    fullname: Zhang
– volume: 112
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0155
  article-title: Effect of acid and oxidative degradation on the structural, rheological, and physiological properties of oat β-glucan
  publication-title: Food Hydrocoll.
  doi: 10.1016/j.foodhyd.2020.106284
  contributor:
    fullname: Qin
– volume: 7
  start-page: 42
  year: 2020
  ident: 10.1016/j.jconrel.2023.05.043_bb0085
  article-title: Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets
  publication-title: Front. Vet. Sci.
  doi: 10.3389/fvets.2020.00042
  contributor:
    fullname: Wang
– volume: 38
  start-page: 2706
  year: 2018
  ident: 10.1016/j.jconrel.2023.05.043_bb0070
  article-title: Preparation of poly (lactic-co-glycolic acid)/polyethylene glycol nanoparticles with surface-modified aptamer S6 and its application on carrier siRNA
  publication-title: Chin. J. Org. Chem.
  doi: 10.6023/cjoc201803050
  contributor:
    fullname: Han
– volume: 164
  start-page: 1461
  year: 2020
  ident: 10.1016/j.jconrel.2023.05.043_bb0065
  article-title: Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of paclitaxel toward prostate cancer cells death
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2020.07.228
  contributor:
    fullname: Faraji Dizaji
– volume: 9
  start-page: 6568
  year: 2019
  ident: 10.1016/j.jconrel.2023.05.043_bb0215
  article-title: Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route
  publication-title: Theranostics
  doi: 10.7150/thno.35353
  contributor:
    fullname: Zhou
– volume: 34
  start-page: 8968
  year: 2013
  ident: 10.1016/j.jconrel.2023.05.043_bb0055
  article-title: Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.07.097
  contributor:
    fullname: Qian
– volume: 127
  start-page: 1301
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0160
  article-title: SARC025 arms 1 and 2: a phase 1 study of the poly (ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma
  publication-title: Cancer
  doi: 10.1002/cncr.33349
  contributor:
    fullname: Chugh
– volume: 64
  start-page: 557
  year: 2012
  ident: 10.1016/j.jconrel.2023.05.043_bb0180
  article-title: Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2011.12.009
  contributor:
    fullname: Ensign
– volume: 13
  start-page: 768
  year: 2023
  ident: 10.1016/j.jconrel.2023.05.043_bb0195
  article-title: β-Glucan and fatty acid based mucoadhesive carrier for gastrointestinal tract specific local and sustained drug delivery
  publication-title: Biomolecules
  doi: 10.3390/biom13050768
  contributor:
    fullname: Esquivel
– volume: 13
  start-page: 3471
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0060
  article-title: PLGA core-shell nano/microparticle delivery system for biomedical application
  publication-title: Polymers
  doi: 10.3390/polym13203471
  contributor:
    fullname: Kim
– volume: 25
  start-page: 235
  year: 2017
  ident: 10.1016/j.jconrel.2023.05.043_bb0050
  article-title: iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy
  publication-title: J. Drug Target.
  doi: 10.1080/1061186X.2016.1238091
  contributor:
    fullname: Liu
– volume: 380
  start-page: 216
  year: 2009
  ident: 10.1016/j.jconrel.2023.05.043_bb0105
  article-title: A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2009.07.005
  contributor:
    fullname: Verma
– volume: 16
  start-page: 227
  year: 2018
  ident: 10.1016/j.jconrel.2023.05.043_bb0140
  article-title: Versatile polymeric microspheres with tumor microenvironment bioreducible degradation, pH-activated surface charge reversal, pH-triggered “off-on” fluorescence and drug release as theranostic nanoplatforms
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.8b00957
  contributor:
    fullname: Pei
– volume: 7
  start-page: eabf0677
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0185
  article-title: Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abf0677
  contributor:
    fullname: Lin
– volume: 104
  start-page: 4038
  year: 2004
  ident: 10.1016/j.jconrel.2023.05.043_bb0165
  article-title: Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages
  publication-title: Blood
  doi: 10.1182/blood-2004-03-1140
  contributor:
    fullname: Herre
– volume: 94
  start-page: 393
  year: 2015
  ident: 10.1016/j.jconrel.2023.05.043_bb0175
  article-title: The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: evaluation of their potential for colon-specific delivery
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2015.06.014
  contributor:
    fullname: Ma
– volume: 16
  start-page: 12118
  year: 2022
  ident: 10.1016/j.jconrel.2023.05.043_bb0150
  article-title: Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c02540
  contributor:
    fullname: Zhao
– volume: 219
  start-page: 1244
  year: 2022
  ident: 10.1016/j.jconrel.2023.05.043_bb0190
  article-title: Research progress on natural β-glucan in intestinal diseases
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2022.08.173
  contributor:
    fullname: Han
– volume: 40
  start-page: 1154
  year: 2022
  ident: 10.1016/j.jconrel.2023.05.043_bb0020
  article-title: Intestine enzyme-responsive polysaccharide-based hydrogel to open epithelial tight junctions for oral delivery of Imatinib against colon cancer
  publication-title: Chin. J. Polym. Sci.
  doi: 10.1007/s10118-022-2726-0
  contributor:
    fullname: Wang
– volume: 9
  start-page: 7458
  year: 2019
  ident: 10.1016/j.jconrel.2023.05.043_bb0030
  article-title: Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer
  publication-title: Theranostics
  doi: 10.7150/thno.38081
  contributor:
    fullname: Han
– volume: 159
  start-page: 39
  year: 2017
  ident: 10.1016/j.jconrel.2023.05.043_bb0075
  article-title: Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2016.12.009
  contributor:
    fullname: Kang
– volume: 17
  start-page: 1666
  year: 2011
  ident: 10.1016/j.jconrel.2023.05.043_bb0090
  article-title: Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i13.1666
  contributor:
    fullname: Sipos
– volume: 316
  start-page: 663
  year: 2017
  ident: 10.1016/j.jconrel.2023.05.043_bb0110
  article-title: Efficient production of hybrid bio-nanomaterials by continuous microchannel emulsification: dye-doped SiO2 and Au-PLGA nanoparticles
  publication-title: Chem. Eng. J.
  doi: 10.1016/j.cej.2017.02.003
  contributor:
    fullname: Larrea
– volume: 42
  start-page: 227
  year: 2022
  ident: 10.1016/j.jconrel.2023.05.043_bb0005
  article-title: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21809
  contributor:
    fullname: Khan
– volume: 33
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0100
  article-title: A noninvasive gut-to-brain oral drug delivery system for treating brain tumors
  publication-title: Adv. Mater.
  doi: 10.1002/adma.202100701
  contributor:
    fullname: Miao
– volume: 134
  start-page: 1296
  year: 2008
  ident: 10.1016/j.jconrel.2023.05.043_bb0010
  article-title: Systemic treatment of colorectal cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.02.098
  contributor:
    fullname: Wolpin
– volume: 78
  start-page: CT095
  year: 2018
  ident: 10.1016/j.jconrel.2023.05.043_bb0035
  article-title: Abstract CT095: Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients (pts) bearing MGMT methylation
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2018-CT095
  contributor:
    fullname: Morano
– volume: 89
  start-page: 58
  year: 2009
  ident: 10.1016/j.jconrel.2023.05.043_bb0210
  article-title: No effect of added β-glucan or of fructooligosaccharide on appetite or energy intake
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.2008.26701
  contributor:
    fullname: Peters
– volume: 10
  start-page: 1743
  year: 2015
  ident: 10.1016/j.jconrel.2023.05.043_bb0130
  article-title: Specifically targeted delivery of protein to phagocytic macrophages
  publication-title: Int. J. Nanomedicine
  contributor:
    fullname: Yu
– volume: 6
  start-page: 2100951
  year: 2022
  ident: 10.1016/j.jconrel.2023.05.043_bb0025
  article-title: Temulence therapy to orthotopic colorectal tumor via oral administration of fungi-based acetaldehyde generator
  publication-title: Small Methods
  doi: 10.1002/smtd.202100951
  contributor:
    fullname: Zhang
– volume: 43
  start-page: 217
  year: 2011
  ident: 10.1016/j.jconrel.2023.05.043_bb0015
  article-title: MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines
  publication-title: Acta Biochim. Biophys. Sin.
  doi: 10.1093/abbs/gmq125
  contributor:
    fullname: Chai
– volume: 458
  start-page: 1180
  year: 2009
  ident: 10.1016/j.jconrel.2023.05.043_bb0125
  article-title: Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
  publication-title: Nature
  doi: 10.1038/nature07774
  contributor:
    fullname: Aouadi
– volume: 31
  start-page: 2009733
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0170
  article-title: Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202009733
  contributor:
    fullname: Fan
– volume: 9
  start-page: 1
  year: 2019
  ident: 10.1016/j.jconrel.2023.05.043_bb0135
  article-title: Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release
  publication-title: Sci. Rep.
  contributor:
    fullname: Chen
– volume: 8
  start-page: 10383
  year: 2014
  ident: 10.1016/j.jconrel.2023.05.043_bb0045
  article-title: Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors
  publication-title: ACS Nano
  doi: 10.1021/nn503735w
  contributor:
    fullname: Stephen
– volume: 10
  start-page: 97
  year: 1997
  ident: 10.1016/j.jconrel.2023.05.043_bb0095
  article-title: Role of organized intestinal lymphoid aggregates in intestinal regeneration
  publication-title: J. Investig. Surg.
  doi: 10.3109/08941939709032139
  contributor:
    fullname: Saxena
– volume: 147
  year: 2020
  ident: 10.1016/j.jconrel.2023.05.043_bb0080
  article-title: Chitosan as a coating material for nanoparticles intended for biomedical applications
  publication-title: React. Funct. Polym.
  doi: 10.1016/j.reactfunctpolym.2019.104459
  contributor:
    fullname: Frank
– volume: 32
  year: 2020
  ident: 10.1016/j.jconrel.2023.05.043_bb0205
  article-title: Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2020.101495
  contributor:
    fullname: Wang
– volume: 253
  year: 2021
  ident: 10.1016/j.jconrel.2023.05.043_bb0200
  article-title: Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2020.117255
  contributor:
    fullname: Zheng
– volume: 7
  start-page: 20890
  year: 2016
  ident: 10.1016/j.jconrel.2023.05.043_bb0115
  article-title: The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7896
  contributor:
    fullname: Xu
– volume: 22
  start-page: 1
  year: 2016
  ident: 10.1016/j.jconrel.2023.05.043_bb0145
  article-title: The simulation of UV spectroscopy and electronic analysis of temozolomide and dacarbazine chemical decomposition to their metabolites
  publication-title: J. Mol. Model.
  doi: 10.1007/s00894-016-3133-7
  contributor:
    fullname: Khalilian
– volume: 93
  start-page: 381
  year: 2016
  ident: 10.1016/j.jconrel.2023.05.043_bb0120
  article-title: Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2016.08.080
  contributor:
    fullname: Thakur
SSID ssj0005347
Score 2.4954243
Snippet Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 347
SubjectTerms Colorectal cancer therapy
Oral drug delivery system
PLGA
Temozolomide
Tumor-specific accumulation
Yeast shell wall
Title Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy
URI https://dx.doi.org/10.1016/j.jconrel.2023.05.043
https://www.ncbi.nlm.nih.gov/pubmed/37277054
https://search.proquest.com/docview/2823042762
Volume 359
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSyMxEB-0vtyLnHp39vwggvhkWptk0_SxyGnvQymcHt5TyOYDLXZbavvQF_92J5vdK_cggrDssgshYWZ25jeZjwAcW45Sa7yimWOeCtsN1ATFKVpOpZwVIohYnHx1LQe34sdddrcG53UtTEyrrHR_0umltq6-tCtqtqcPD-3fCFYUj1FBHsNhMluHDTRHQjRgo__95-B6lenBRaqalorGAatCnvaoNUK3c-ZjEILxsoen4K-ZqNcgaGmKLj7CZoUhST8tcwvWfLENJ8PUhHp5Sm5WNVVPp-SEDFftqZc78OdvPK6HxB17MvZj9JYLT60ZTxbhEZWLI8Nfl31SmALd6TQDmT6aeQS3BG_EF_dl1gCx8TEjqYJr-QluL77dnA9odboCtUiEOc26XKoQLJPWWdPLO6GHrnLOMsfxkjIoGfKAAA8Z1jHO855C99BKx10QmbD8MzSKSeF3gYiOZwax4Zl3XhiO_nluGHc-Mz3pGFNNaNUE1dPUREPX2WUjXXFARw7os0wjB5qgarLr_6RBo6J_a-hRzSaNf0okJpJxsnjSrIwpMtT-TfiS-PdvNRxhXBfR69f3T7wHH-JbSuXdh8Z8tvAHCFjm-SGst547h5VYvgD7sOvG
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB5S59BeSvp204cKJacojvWyfDShqdM4xlCnpCeh1YPGxGvj2Af_-45WuzU9hEJh2YVdhMTM7Mw3mocAPjuOUmuDptKzQIXrRWqj5hQtp9beCRFFKk6-Gqvhtfh2I2_24KyphUlplbXuzzq90tb1m05Nzc7y9rbzHcGK5ikqyFM4TMlHsC9krytasD-4uByOd5keXOSqaaVpGrAr5OnMTmbodq5CCkIwXvXwFPwhE_UQBK1M0fkBPK0xJBnkZT6DvVA-h6NJbkK9PSbTXU3V_TE5IpNde-rtC_jxMx3XQ9KOPZmHOXrLZaDOzhebeIfKxZPJ6OuAlLZEdzrPQJZ3dp3ALcEbCeWvKmuAuPRYkVzBtX0J1-dfpmdDWp-uQB0SYU1ljysdo2PKeWf7RTf20VUumPQcL6WiVrGICPCQYV3rA-9rdA-d8txHIYXjr6BVLsrwBojoBmYRG54GH4Tl6J8XlnEfpO0rz5huw0lDULPMTTRMk102MzUHTOKAOZUGOdAG3ZDd_CUNBhX9v4Z-athk8E9JxEQyLjb3hlUxRYbavw2vM__-rIYjjOshen37_xN_hMfD6dXIjC7Gl4fwJH3Jab3voLVebcJ7BC_r4kMtnL8Bq4XtuA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Yeast+cell+membrane-camouflaged+PLGA+nanoparticle+platform+for+enhanced+cancer+therapy&rft.jtitle=Journal+of+controlled+release&rft.au=He%2C+Yu&rft.au=Chen%2C+Qi-Wen&rft.au=Yu%2C+Jin-Xin&rft.au=Qin%2C+Si-Yong&rft.date=2023-07-01&rft.eissn=1873-4995&rft.volume=359&rft.spage=347&rft_id=info:doi/10.1016%2Fj.jconrel.2023.05.043&rft_id=info%3Apmid%2F37277054&rft.externalDocID=37277054
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon